Therapy (HCV)
"Treatment of Chronic Hepatitis C Genotype 4 With Alpha-interferon in Saudi Arabia: A Multicenter Study."
Published in Hepatitis Weekly, June 1st, 1998
According to the authors' abstract of an article published in Hepato - Gastroenterology, "Background/Aim: Several studies have indicated that there are certain predictive factors (gender, duration of infection with HCV, cirrhosis and genotype of HCV) of a better response with a-interferon treatment in patients with chronic hepatitis C. The aim of this study was to evaluate these factors in Saudis and other Arab nationals with chronic hepatitis C - genotype 4 - undergoing alpha-interferon treatment. Methodology: A multicenter study was conducted between 1992 and 1994 on 80 consecutive patients who were prospectively recruited and randomized in treatment and control...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1998-06-01)
More Articles from Hepatitis Weekly
- Conference Coverage (ASM)
Chlorinated Water Kills Hepatitis A Virus - Dual Infection (HCV/HBV)
HBC May Be Factor in HCV-Related Liver Cancer - Genotyping (Hepatitis)
GBV-C/HGV Not Important in Type 1 Autoimmune Hepatitis - Transmission (HEV)
Hepatitis E Virus is Not Endemic in Taiwan - Virology (HCV)
Serum Viral Level Measures Liver Viral Burden - Conference Coverage (ECPI Combination Vaccines)
Developing World Needs Combo Vaccine - But Who Will Pay? - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
